Evidence map›Paper›PMID 38600166›Full record

ArticleScientific reports2024

Acceptability of COVID-19 booster vaccine in malaysia: a cross-sectional study.

Cheryl Minn Jee Khoo, Eve Zhi Qing Dea, Li Yeow Law, Sharon Siew Tong Wong, Khuen Yen Ng, Athirah Bakhtiar

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cheryl Minn Jee KhooSchool of Pharmacy, Monash University Malaysia, 47500, Bandar Sunway, Selangor, Malaysia.
Eve Zhi Qing DeaSchool of Pharmacy, Monash University Malaysia, 47500, Bandar Sunway, Selangor, Malaysia.
Li Yeow LawSchool of Pharmacy, Monash University Malaysia, 47500, Bandar Sunway, Selangor, Malaysia.
Sharon Siew Tong WongSchool of Pharmacy, Monash University Malaysia, 47500, Bandar Sunway, Selangor, Malaysia.
Khuen Yen NgSchool of Pharmacy, Monash University Malaysia, 47500, Bandar Sunway, Selangor, Malaysia.
Athirah BakhtiarSchool of Pharmacy, Monash University Malaysia, 47500, Bandar Sunway, Selangor, Malaysia. athirah.bakhtiar@monash.edu.
Monash University Malaysia · MY

Funding

Ministry of Higher Education, Malaysia FRGS/1/2021/SKK03/MUSM/03/1
6 · The paper itself

Abstract

Despite the high efficacy and safety demonstrated in clinical trials, COVID-19 booster vaccination rates in Malaysia remain below 50% among the general public. This study explores the factors influencing public acceptance of the COVID-19 booster vaccine among the Malaysian population. The questionnaire included variables on sociodemographics, knowledge, and the Health Belief Model (HBM) constructs. Based on the Chi-squared test of contingencies, a t-test and multivariate logistic regression analysis on 411 collected responses, the findings revealed that older participants, individuals of Chinese ethnicity, and those with higher education levels and incomes were more willing to accept booster vaccinations. The analysis further identified perceived susceptibility, perceived severity and perceived barriers as significant predictors influencing booster vaccination acceptance rates. Healthcare policymakers may consider targeting interventions to diminish the obstacles associated with booster vaccinations. These intervention strategies include implementing health intervention programmes, such as public health awareness initiatives, to raise awareness of the risks and severity of COVID-19, ultimately encouraging higher uptake of booster vaccines.

Indexed as

COVID-19COVID-19 VaccinesCross-Sectional StudiesEast Asian PeopleHumansMalaysiaSoutheast Asian PeopleVaccinationCOVID-19 VaccinesBooster vaccinationCOVID-19Health Belief Model (HBM)Sociodemographics

Identifiers

PMID38600166
PMCPMC11006945
OpenAlexW4394687110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.